Mikhail Kosiborod
Heart Failure & Transplant
Saint Luke's Health System
About
Mikhail Kosiborod works in Heart Failure & Transplant affiliated with Saint Luke's Health System.
Mikhail Kosiborod is a cardiologist serving as Senior Vice President of Late-Stage Development for Cardiovascular, Renal and Metabolism at AstraZeneca. He holds the position of Professor of Medicine at the University of Missouri-Kansas City and is affiliated with Saint Luke's Mid America Heart Institute. He also has research affiliations with The George Institute for Global Health at UNSW Sydney.
Research focus
SGLT2 Inhibitors in Heart FailureHeart Failure with Preserved Ejection FractionCardiometabolic SyndromesCardiorenal SyndromesDiabetes and Cardiovascular Disease Management
Impact
837 pubs · 60,048 cites · h-index 113
Training
MD
Mount Sinai School of Medicine
1997
Residency in Internal Medicine
Yale University School of Medicine
Fellowship in Cardiovascular Medicine
Yale University School of Medicine
2005
Affiliations
Work Experience
Senior Vice President Late-Stage Development, CVRM
AstraZeneca · 2025 - Present
Vice President of Research
Saint Luke’s Health System · 2005 - Present
Director of Cardiometabolic Research
Saint Luke’s Mid America Heart Institute · 2005 - Present
Professor of Medicine
University of Missouri–Kansas City · 2005 - Present